Condition
Hepatic Insufficiency clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Hepatic Insufficiency clinical trials that are recruiting, at sites in 5 countries (most in United States (2), Hungary (2), France (1)). By phase: Phase 1 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest Hepatic Insufficiency clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safety and how the drug behaves in adults with moderate to severe liver impairment | Phase 1 | Chandler, Arizona and 3 other locations | Recruiting | Apr 30, 2026 |
| Eloralintide in people with and without liver damage | Phase 1 | Orlando, Florida and 2 other locations | Recruiting | Feb 11, 2026 |
| Diagnosing lymphohistiocytic hemophagocytosis in intensive care patients with liver disease | — | Strasbourg | Recruiting | Jan 15, 2026 |
| How LY3537031 is processed and tolerated in people with normal or impaired liver function | Phase 1 | Kistarcsa and 2 other locations | Recruiting | Sep 10, 2025 |
All recruiting trials (4)
-
Safety and how the drug behaves in adults with moderate to severe liver impairment
This study tests the safety and how INCB123667 moves through the body when taken by adults with moderate to severe liver impairment.
-
Eloralintide in people with and without liver damage
This Phase 1 study will test how the medicine eloralintide (LY3841136) is absorbed, processed, and tolerated in adults with healthy livers and in those with mild, moderate, or severe liver damage.
-
Diagnosing lymphohistiocytic hemophagocytosis in intensive care patients with liver disease
This study will test whether the HScore can accurately detect lymphohistiocytic hemophagocytosis in adults with hepatocellular insufficiency or cirrhosis admitted to intensive care.
-
How LY3537031 is processed and tolerated in people with normal or impaired liver function
This trial will test how LY3537031 is absorbed, distributed, and cleared and whether it is safe when given under the skin to adults with normal liver function and to adults with mild, moderate, or severe liver impairment.
Related topics
Quick answers
How many Hepatic Insufficiency clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (2 trials), Hungary (2 trials), France (1 trial), New Zealand (1 trial), Slovakia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.